Affiliations
AffiliationsItem in Clipboard
Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020Hannah K Weir et al. Prev Chronic Dis. 2016.
doi: 10.5888/pcd13.160211. AffiliationsItem in Clipboard
AbstractIntroduction: Heart disease and cancer are the first and second leading causes of death in the United States. Age-standardized death rates (risk) have declined since the 1960s for heart disease and for cancer since the 1990s, whereas the overall number of heart disease deaths declined and cancer deaths increased. We analyzed mortality data to evaluate and project the effect of risk reduction, population growth, and aging on the number of heart disease and cancer deaths to the year 2020.
Methods: We used mortality data, population estimates, and population projections to estimate and predict heart disease and cancer deaths from 1969 through 2020 and to apportion changes in deaths resulting from population risk, growth, and aging.
Results: We predicted that from 1969 through 2020, the number of heart disease deaths would decrease 21.3% among men (-73.9% risk, 17.9% growth, 34.7% aging) and 13.4% among women (-73.3% risk, 17.1% growth, 42.8% aging) while the number of cancer deaths would increase 91.1% among men (-33.5% risk, 45.6% growth, 79.0% aging) and 101.1% among women (-23.8% risk, 48.8% growth, 76.0% aging). We predicted that cancer would become the leading cause of death around 2016, although sex-specific crossover years varied.
Conclusion: Risk of death declined more steeply for heart disease than cancer, offset the increase in heart disease deaths, and partially offset the increase in cancer deaths resulting from demographic changes over the past 4 decades. If current trends continue, cancer will become the leading cause of death by 2020.
FiguresFigure 1
Trends in observed (1969–2014) and…
Figure 1
Trends in observed (1969–2014) and predicted (2015–2020) heart disease and cancer deaths attributed…
Figure 1Trends in observed (1969–2014) and predicted (2015–2020) heart disease and cancer deaths attributed to the average person’s risk of dying from the disease (ie, population risk, accounting for such factors as changes in diagnostic and treatment practices), population growth, and population aging, by sex. The blue dashed line (baseline) is the number of deaths from heart disease or cancer that occurred in 1969. The dark yellow (1969–2014) and light yellow (2015–2020) line represents the total number of deaths that would have occurred each year if the population size and age structure remained the same as it was in 1969; this line reflects the effect of changes in population risk. The black (1969–2014) and gray (2015–2020) line represents the total number of deaths that would have occurred if the age structure had remained the same as it was in 1969; this line reflects the effect of changes in risk and population growth. The dark orange (1969–2014) and light orange (2015–2020) line represents the expected number of deaths that actually occurred and thus reflects the combined impact of changes in population risk, growth, and aging. A. Heart disease deaths among men. The number of heart disease deaths attributed to risk declined while the number of heart disease deaths resulting from population growth and aging increased. Observed heart disease deaths declined from 1969 through 2014 and are predicted to increase through 2020, primarily because of an aging population. B. Number of cancer deaths among men. The number of cancer deaths attributed to risk increased from 1969 through 2000 and declined from 2000 forward. The number of cancer deaths resulting from population growth and aging increased. Observed cancer deaths increased from 1969 through 2014 and are predicted to continue to increase through 2020, primarily because of an aging population. C. Number of heart disease deaths among women. The number of heart disease deaths attributed to risk declined while the number of heart disease deaths resulting from population growth and aging increased. Observed heart disease deaths increased from 1969 through 1995, primarily because of an aging population. Observed heart disease deaths are predicted to continue to decrease through 2020, primarily because of continued risk reduction. D. Number of cancer deaths among women. The number of cancer deaths attributed to risk increased from 1969 through 2000 and declined from 2000 forward. The number of cancer deaths resulting from population growth and aging increased. Observed cancer deaths increased from 1969 through 2015 and are predicted to continue to increase through 2020, primarily because of an aging population.
Figure 2
Age-standardized death rates (ASDR) and…
Figure 2
Age-standardized death rates (ASDR) and the observed and predicted number of cancer and…
Figure 2Age-standardized death rates (ASDR) and the observed and predicted number of cancer and heart disease deaths from 1969 through 2020 for men and women combined. [Table: see text]
Similar articlesMurray CJ, Lopez AD. Murray CJ, et al. Lancet. 1997 May 24;349(9064):1498-504. doi: 10.1016/S0140-6736(96)07492-2. Lancet. 1997. PMID: 9167458
Weir HK, Thompson TD, Soman A, Møller B, Leadbetter S, White MC. Weir HK, et al. Prev Chronic Dis. 2015 Jul 2;12:E104. doi: 10.5888/pcd12.140482. Prev Chronic Dis. 2015. PMID: 26133647 Free PMC article.
Sonnenschein E, Brody JA. Sonnenschein E, et al. J Gerontol B Psychol Sci Soc Sci. 2005 Mar;60(2):S110-2. doi: 10.1093/geronb/60.2.s110. J Gerontol B Psychol Sci Soc Sci. 2005. PMID: 15746026
Stover J, Way P. Stover J, et al. AIDS. 1998;12 Suppl 1:S29-39. AIDS. 1998. PMID: 9677187 Review.
Ritchey MD, Wall HK, George MG, Wright JS. Ritchey MD, et al. Trends Cardiovasc Med. 2020 Aug;30(6):364-374. doi: 10.1016/j.tcm.2019.09.005. Epub 2019 Sep 27. Trends Cardiovasc Med. 2020. PMID: 31607635 Free PMC article. Review.
El Haji H, Sbihi N, Guermah B, Souadka A, Ghogho M. El Haji H, et al. PLoS One. 2024 Aug 14;19(8):e0308905. doi: 10.1371/journal.pone.0308905. eCollection 2024. PLoS One. 2024. PMID: 39141659 Free PMC article.
Ye W, Wang J, Little PJ, Zou J, Zheng Z, Lu J, Yin Y, Liu H, Zhang D, Liu P, Xu S, Ye W, Liu Z. Ye W, et al. Acta Pharm Sin B. 2024 Jan;14(1):1-19. doi: 10.1016/j.apsb.2023.09.014. Epub 2023 Sep 23. Acta Pharm Sin B. 2024. PMID: 38239238 Free PMC article. Review.
D'Souza MJ, Li RC, Wentzien DE. D'Souza MJ, et al. Res Health Sci. 2019;4(4):327-346. doi: 10.22158/rhs.v4n4p327. Epub 2019 Nov 12. Res Health Sci. 2019. PMID: 31768484 Free PMC article.
Alsamri H, Al Dhaheri Y, Iratni R. Alsamri H, et al. Antioxidants (Basel). 2023 Jun 27;12(7):1349. doi: 10.3390/antiox12071349. Antioxidants (Basel). 2023. PMID: 37507889 Free PMC article. Review.
Alkahtani HM, Alanazi MM, Aleanizy FS, Alqahtani FY, Alhoshani A, Alanazi FE, Almehizia AA, Abdalla AN, Alanazi MG, El-Azab AS, Abdel-Aziz AA. Alkahtani HM, et al. Saudi Pharm J. 2019 Jul;27(5):682-693. doi: 10.1016/j.jsps.2019.04.003. Epub 2019 Apr 3. Saudi Pharm J. 2019. PMID: 31297023 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3